NASDAQ:MCRB

Seres Therapeutics Stock News

etoro logo Buy MCRB
*Your capital is at risk
$4.83
+0.0500 (+1.05%)
At Close: Jul 31, 2026
Entre os 20 fundos de renda fixa com maior entrada de cotistas entre janeiro e junho, 15 perderam para o CDI, mostra levantamento do InfoMoney
A settlement has been announced between Libre by Nexus Inc. in which it will cease transacting immigration bonds in the California, phase out the use of
Regulatory News: DEINOVE (Paris:ALDEI) (Euronext Growth Paris: ALDEI), a French biotech company that uses its lead generation platform to develop inno
RPS Capital: a Gestora investida pelos principais Family Offices do país abre ao varejo fundos de ações descorrelacionados para diferentes
Seres Therapeutics (NASDAQ:MCRB) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Tuesday, Zacks.com reports. The brokerage current
ICIS, Teil von RELX, gab heute die Übernahme von Chemical Data, LLC (CDI), einem führenden Anbieter von US-Preis-Benchmarks für petrochemische Produkte, Marktanalysen und vorausschauende Analysen m
Proceeds will be used to accelerate Sezzle’s growth strategy and strengthen its balance sheet.
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
The capital raising includes an institutional placement to raise A$79.1 million, followed by a non-underwritten Security Purchase Plan that aims to raise approximately A$7.2 million.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Akero Therapeutics Inc (...
Seres Therapeutics (MCRB) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.
Investment allows firm to expand service offerings and geographical reach NEW YORK--(BUSINESS WIRE)--#cloud--Computer Design & Integration LLC ("CDI" or "the Company") announce
Investors need to pay close attention to Seres Therapeutics (MCRB) stock based on the movements in the options market lately.
Flagship Pioneering today announced the unveiling of Tessera Therapeutics, Inc. a new company with the mission of curing disease by writing in the code of life. Tessera is pioneering Gene Writing™,
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE